T cell activation is insufficient to drive SIV disease progression
- Univ. of Pittsburgh, PA (United States); Tulane Univ., Covington, LA (United States)
- Tulane Univ., Covington, LA (United States)
- Univ. of Pittsburgh, PA (United States)
- Rush University Medical Center, Chicago, IL (United States)
- Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
Resolution of T cell activation and inflammation is a key determinant of the lack of SIV disease progression in African green monkeys (AGMs). Although frequently considered together, T cell activation occurs in response to viral stimulation of acquired immunity, while inflammation reflects innate immune responses to mucosal injury. We dissociated T cell activation from inflammation through regulatory T cell (Treg) depletion with Ontak (interleukin-2 coupled with diphtheria toxin) during early SIV infection of AGMs. This intervention abolished control of T cell immune activation beyond the transition from acute to chronic infection. Ontak had no effect on gut barrier integrity, microbial translocation, inflammation, and hypercoagulation, despite increasing T cell activation. Ontak administration increased macrophage counts yet decreased their activation. Persistent T cell activation influenced SIV pathogenesis, shifting the ramp-up in viral replication to earlier time points, prolonging the high levels of replication, and delaying CD4+ T cell restoration yet without any clinical or biological sign of disease progression in Treg-depleted AGMs. Thus, by inducing T cell activation without damaging mucosal barrier integrity, we showed that systemic T cell activation per se is not sufficient to drive disease progression, which suggests that control of systemic inflammation (likely through maintenance of gut integrity) is the key determinant of lack of disease progression in natural hosts of SIVs.
- Research Organization:
- Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
- Sponsoring Organization:
- National Institutes of Health (NIH); USDOE National Nuclear Security Administration (NNSA)
- Grant/Contract Number:
- 89233218CNA000001
- OSTI ID:
- 2222627
- Report Number(s):
- LA-UR--23-24126
- Journal Information:
- JCI Insight, Journal Name: JCI Insight Journal Issue: 14 Vol. 8; ISSN 2379-3708
- Publisher:
- American Society for Clinical InvestigationCopyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
Experimentally-induced immune activation in natural hosts of SIV induces significant increases in viral replication and CD4+ T cell depletion
Kinetics of Myeloid Dendritic Cell Trafficking and Activation: Impact on Progressive, Nonprogressive and Controlled SIV Infections
Experimental depletion of CD8+ cells in acutely SIVagm-Infected African Green Monkeys results in increased viral replication
Journal Article
·
Mon Dec 31 23:00:00 EST 2007
· Journal of Immunology
·
OSTI ID:960542
Kinetics of Myeloid Dendritic Cell Trafficking and Activation: Impact on Progressive, Nonprogressive and Controlled SIV Infections
Journal Article
·
Wed Oct 02 20:00:00 EDT 2013
· PLoS Pathogens
·
OSTI ID:1627907
Experimental depletion of CD8+ cells in acutely SIVagm-Infected African Green Monkeys results in increased viral replication
Journal Article
·
Mon May 10 20:00:00 EDT 2010
· Retrovirology
·
OSTI ID:1626607